Malaria News and Research

Latest Malaria News and Research

COVID-19’s adverse impact on the cardiovascular system

COVID-19 can cause serious cardiovascular complications including heart failure, heart attacks and blood clots that can lead to strokes, emergency medicine doctors report in a new scientific paper.

15 May 2020

Activity of malaria-causing parasite is driven by the parasite's own inherent clocks

The activity of the parasite that causes malaria is driven by the parasite's own inherent clock, new research led by UT Southwestern scientists suggests. The findings, published this week in Science, could lead to new ways to fight this pervasive and deadly disease.

15 May 2020

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

Scientists from the Walter Reed Army Institute of Research joined partners at Duke University, Florida Atlantic University and Montana State University to publish a study providing clear evidence that malaria's characteristic cycle of fever and chills is a result of the parasite's own influence--not factors from the host.

15 May 2020

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

Drug counterfeiters are using corona pandemic to make profits in Africa

Drug counterfeiters are using the corona pandemic to make profits in Africa selling completely ineffective or even harmful medicines.

14 May 2020

New combination offers complete protection against malaria

This ingredient is an essential component of the malaria parasite, a protein known as RPL6, which makes the parasite "visible" to a type of immune cells, the T cells, in the liver.

14 May 2020

Researchers launch clinical trial to test the efficacy of antidepressant against COVID-19

An antidepressant medication is being tested as a potential treatment for COVID-19 after University of Virginia School of Medicine researchers determined it may prevent dangerous overreactions by the immune system.

13 May 2020

Researchers use “gene drive” technology to eliminate malaria mosquitoes in lab experiments

A modification that creates more male offspring was able to eliminate populations of malaria mosquitoes in lab experiments.

13 May 2020

Platelets can intensify inflammatory processes, study shows

Platelets not only play a key role in blood clotting, but can also significantly intensify inflammatory processes.

12 May 2020

Study provides genetic explanation behind the sex bias observed in certain diseases

Some diseases exhibit a clear sex bias, occurring more often, hitting harder or eliciting different symptoms in men or women.

12 May 2020

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

Over the past few months, doctors resorted to repurposing medicines that have already been approved for other diseases to treat coronavirus patients. One drug that was widely used in the pandemic, hydroxychloroquine, has been found to be ineffective in treating the viral infection.

11 May 2020

New diagnostic approach has potential to enhance infectious diseases surveillance

A new technique could provide vital information about a community's immunity to infectious diseases including malaria and COVID-19.

11 May 2020

Clinical trial launched to evaluate experimental COVID-19 therapies

Clinical leaders from the University of Kentucky's Markey Cancer Center, College of Medicine and College of Pharmacy have launched a clinical trial for experimental therapies to treat patients infected with COVID-19.

11 May 2020

New HIV vaccine better at preventing infection and offers more durable protection

Researchers from the Emory Consortium for Innovative AIDS Research in Nonhuman Primates and their colleagues across North America have shown a new HIV vaccine is better at preventing infection and lasts longer, continuing to protect one year after vaccination.

11 May 2020

Scientists discover fungus that blocks malaria transmission from mosquitoes to people

A fungus that lives in malaria-carrying mosquitoes could boost global efforts to control the disease, which kills about half a million people — mostly children under five — every year.

7 May 2020

Hydroxychloroquine shown to slow recovery for COVID-19 patients

As researchers try to piece together a therapeutic strategy against the ongoing COVID-19 pandemic, a recent retrospective study from Cleveland Clinic Abu Dhabi, assessed the Hydroxychloroquine's efficacy in increasing SARS-CoV-2 viral clearance, finding that it appeared to significantly slow viral clearance in mild to moderately ill COVID-19 patients.

5 May 2020

UBC discovery could pave way for developing new anti-malarial drugs

For the first time, UBC researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart.

2 May 2020

Study could bring malaria eradication efforts closer to fruition

Strategies that treat households in the broad vicinity of a recent malaria case with anti-malarial drugs, insecticides, or both could significantly reduce malaria in low-transmission settings, a challenge with approaches currently in use, a study led by UT Southwestern scientists suggests.

30 Apr 2020

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.

30 Apr 2020

Malaria News and Research

Latest Malaria News and Research

COVID-19’s adverse impact on the cardiovascular system

Activity of malaria-causing parasite is driven by the parasite's own inherent clocks

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

ACTG initiates clinical trial to evaluate treatment for COVID-19

Drug counterfeiters are using corona pandemic to make profits in Africa

New combination offers complete protection against malaria

Researchers launch clinical trial to test the efficacy of antidepressant against COVID-19

Researchers use “gene drive” technology to eliminate malaria mosquitoes in lab experiments

Platelets can intensify inflammatory processes, study shows

Study provides genetic explanation behind the sex bias observed in certain diseases

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

New diagnostic approach has potential to enhance infectious diseases surveillance

Clinical trial launched to evaluate experimental COVID-19 therapies

New HIV vaccine better at preventing infection and offers more durable protection

Scientists discover fungus that blocks malaria transmission from mosquitoes to people

Hydroxychloroquine shown to slow recovery for COVID-19 patients

UBC discovery could pave way for developing new anti-malarial drugs

Study could bring malaria eradication efforts closer to fruition

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Using Lung Simulators to Help Tackle COVID-19

Predicting How Contact Tracing Can Control the Spread of COVID-19

Measuring the binding of SARS-CoV-2 Antibodies to the COVID Spike Protein using SPR

Malaria News and Research

Latest Malaria News and Research

Newsletters you may be interested in